Security Bulletin: NVIDIA GeForce Experience contains a vulnerability in NVIDIA Web Helper.exe (repackaged Node.js)

NVIDIA GeForce Experience addresses the bypassing of application whitelisting through NVIDIA bundled Node.js

Go to NVIDIA Product Security.

Vulnerability Details

The following section summarizes the vulnerability and CVSS risk assessment.

CVE-2017-6250

NVIDIA GeForce Experience contains a vulnerability in NVIDIA Web Helper.exe, where untrusted script execution may lead to violation of application execution policy and local code execution.

CVSS Base Score: 8.8
CVSS Temporal Score: 8.2
CVSS Vector: CVSS:3.0/AV:L/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H/E:F/RL:O/RC:C

NVIDIA’s risk assessment is based on an average of risk across a diverse set of installed systems and may not represent the true risk of your local installation. NVIDIA recommends consulting a security or IT professional to evaluate the risk of your specific configuration.

Affected Products

Fixes

The OTA update will automatically apply the fix. You can also download the fix from the NVIDIA GeForce Experience Download page.

Mitigations

None.

Acknowledgements

None.

Revision History

Disclaimer

ALL NVIDIA INFORMATION, DESIGN SPECIFICATIONS, REFERENCE BOARDS, FILES, DRAWINGS, DIAGNOSTICS, LISTS, AND OTHER DOCUMENTS (TOGETHER AND SEPARATELY, “MATERIALS”) ARE BEING PROVIDED “AS IS.” NVIDIA MAKES NO WARRANTIES, EXPRESS, IMPLIED, STATUTORY, OR OTHERWISE WITH RESPECT TO THE MATERIALS, AND ALL EXPRESS OR IMPLIED CONDITIONS, REPRESENTATIONS AND WARRANTIES, INCLUDING ANY IMPLIED WARRANTY OR CONDITION OF TITLE, MERCHANTABILITY, SATISFACTORY QUALITY, FITNESS FOR A PARTICULAR PURPOSE AND NON-INFRINGEMENT, ARE HEREBY EXCLUDED TO THE MAXIMUM EXTENT PERMITTED BY LAW.

Information furnished is believed to be accurate and reliable. However, NVIDIA Corporation assumes no responsibility for the consequences of use of such information or for any infringement of patents or other rights of third parties that may result from its use. No license is granted by implication or otherwise under any patent or patent rights of NVIDIA Corporation. Specifications mentioned in this publication are subject to change without notice. This publication supersedes and replaces all information previously supplied. NVIDIA Corporation products are not authorized for use as critical components in life support devices or systems without express written approval of NVIDIA Corporation.